No Data
No Data
China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk
WuXi Biologics (Cayman) Subsidiary to Sell Vaccines Manufacturing Facility in Ireland for $500 Million
Wuxi Bio's Ireland Facility Sale Likely to Help With Cash Flow -- Market Talk
Express News | Candid - Plans to Complete Ind Enabling Studies to Enable First-in-Human Studies in First Half of 2026
Express News | Candid Therapeutics - WuXi Biologics to Receive up to $925 Million in Payments and Milestones
WuXi Biologics Announces Agreement With Candid Therapeutics on Trispecific T-cell Engager